Pegulicianine Acetate Patent Expiration
Pegulicianine Acetate was first introduced by Lumicell Inc
Pegulicianine Acetate Patents
Given below is the list of patents protecting Pegulicianine Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lumisight | US9763577 | Imaging agent for detection of diseased cells | Sep 14, 2034 | Lumicell |
| Lumisight | US10285759 | Methods and system for image guided cell ablation with microscopic resolution | Dec 08, 2031 | Lumicell |
| Lumisight | US9032965 | Methods and system for image guided cell ablation with microscopic resolution | Dec 08, 2031 | Lumicell |
| Lumisight | US9532835 | Methods and system for image guided cell ablation with microscopic resolution | Dec 08, 2031 | Lumicell |
| Lumisight | US9155471 | Methods and systems for spatially identifying abnormal cells | Oct 12, 2031 | Lumicell |
Pegulicianine Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List